Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP

British Journal of Haematology

Volumn 155, Issue 2, 2011, Pages 274-277

  Testoni, Monica ^a   Kwee, Ivo ^a,b   Greiner, Timothy C ^c   Montes Moreno, Santiago ^d   Vose, Julie ^c   Chan, Wing C ^c   Chiappella, Annalisa ^e   Baldini, Luca ^f   Ferreri, Andrés J M ^g   Gaidano, Gianluca ^h   Mian, Michael ^a,i   Zucca, Emanuele ^a   Bertoni, Francesco ^a  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b DALLE MOLLE INSTITUTE FOR ARTIFICIAL INTELLIGENCE IDSIA   (Switzerland)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^d Centro Nacional de Investigaciones Oncológicas   (Spain)

^e MOLINETTE HOSPITAL   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

^g SAN RAFFAELE HOSPITAL   (Italy)

^h UNIVERSITY OF EASTERN PIEDMONT   (Italy)

ⁱ Azienda Ospedaliera S Maurizio   (Italy)

Author keywords

ArrayCGH; Lymphomas; Malignant lymphomas; MYC

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; MESSENGER RNA; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CHROMOSOME 12P; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 1Q; CHROMOSOME 2P; CHROMOSOME 5P; CHROMOSOME 5Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME 9Q; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE EXPRESSION; GENE LOCUS; GENE TRANSLOCATION; GENETIC GAIN; HUMAN; LARGE CELL LYMPHOMA; LETTER; MAJOR CLINICAL STUDY; ONCOGENE MYC; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMPARATIVE GENOMIC HYBRIDIZATION; CYCLOPHOSPHAMIDE; DOXORUBICIN; GENES, MYC; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA, LARGE B-CELL, DIFFUSE; PREDNISONE; PROGNOSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 80051576860     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08675.x     Document Type: Letter

References (9)

1. Aukema, S.M., Siebert, R., Schuuring, E., van Imhoff, G.W., Kluin-Nelemans, H., Boerma, E.J. & Kluin, P.M. (2011) Double hit B-cell lymphomas. Blood, 117, 2319-2331.
2. Barrans, S., Crouch, S., Smith, A., Turner, K., Owen, R., Patmore, R., Roman, E. & Jack, A. (2010) Rearrangement of MYC is associated with poor prognosis in patients with diffuse large B-cell lymphoma treated in the era of rituximab. Journal of Clinical Oncology, 28, 3360-3365.
3. Boerma, E.G., Siebert, R., Kluin, P.M. & Baudis, M. (2009) Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge. Leukemia, 23, 225-234.
4. Klapproth, K. & Wirth, T. (2010) Advances in the understanding of MYC-induced lymphomagenesis. British Journal of Haematology, 149, 484-497.
5. Lenz, G. & Staudt, L.M. (2010) Aggressive lymphomas. New England Journal of Medicine, 362, 1417-1429.
6. Savage, K.J., Johnson, N.A., Ben-Neriah, S., Connors, J.M., Sehn, L.H., Farinha, P., Horsman, D.E. & Gascoyne, R.D. (2009) MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood, 114, 3533-3537.
7. Scandurra, M., Mian, M., Greiner, T.C., Rancoita, P.M.V., de Campos, C.P., Chan, W.C., Vose, J.M., Chigrinova, E., Inghirami, G., Chiappella, A., Baldini, L., Ponzoni, M., Ferreri, A.J.M., Franceschetti, S., Gaidano, G., Moreno, S.M., Piris, M.A., Facchetti, F., Tucci, A., Nomdedeu, J.F., Lazure, T., Lambotte, O., Uccella, S., Pinotti, G., Pruneri, G., Martinelli, G., Young, K.H., Tibiletti, M.G., Rinaldi, A., Zucca, E., Kwee, I. & Bertoni, F. (2010) Genomic lesions associated with a different clinical outcome in diffuse large B-cell lymphoma treated with R-CHOP. British Journal of Haematology, 151, 221-231.
8. Stasik, C.J., Nitta, H., Zhang, W., Mosher, C.H., Cook, J.R., Tubbs, R.R., Unger, J.M., Brooks, T.A., Persky, D.O., Wilkinson, S.T., Grogan, T.M. & Rimsza, L.M. (2010) Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma. Haematologica, 95, 597-603.
9. Yoon, S.O., Jeon, Y.K., Paik, J.H., Kim, W.Y., Kim, Y.A., Kim, J.E. & Kim, C.W. (2008) MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type. Histopathology, 53, 205-217.